132 related articles for article (PubMed ID: 11755339)
1. N-acyl-L-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformation.
Chen L; Tilley J; Trilles RV; Yun W; Fry D; Cook C; Rowan K; Schwinge V; Campbell R
Bioorg Med Chem Lett; 2002 Jan; 12(2):137-40. PubMed ID: 11755339
[TBL] [Abstract][Full Text] [Related]
2. N-benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
Chen L; Tilley JW; Guthrie RW; Mennona F; Huang TN; Kaplan G; Trilles R; Miklowski D; Huby N; Schwinge V; Wolitzky B; Rowan K
Bioorg Med Chem Lett; 2000 Apr; 10(8):729-33. PubMed ID: 10782674
[TBL] [Abstract][Full Text] [Related]
3. N-acyl phenylalanine analogues as potent small molecule VLA-4 antagonists.
Chen L; Tilley JW; Huang TN; Miklowski D; Trilles R; Guthrie RW; Luk K; Hanglow A; Rowan K; Schwinge V; Wolitzky B
Bioorg Med Chem Lett; 2000 Apr; 10(8):725-7. PubMed ID: 10782673
[TBL] [Abstract][Full Text] [Related]
4. Carbacyclic peptide mimetics as VCAM-VLA-4 antagonists.
Tilley J; Kaplan G; Fotouhi N; Wolitzky B; Rowan K
Bioorg Med Chem Lett; 2000 Jun; 10(11):1163-5. PubMed ID: 10866372
[TBL] [Abstract][Full Text] [Related]
5. Cyclic thioether peptide mimetics as VCAM-VLA-4 antagonists.
Fotouhi N; Joshi P; Tilley JW; Rowan K; Schwinge V; Wolitzky B
Bioorg Med Chem Lett; 2000 Jun; 10(11):1167-9. PubMed ID: 10866373
[TBL] [Abstract][Full Text] [Related]
6. N-aryl 2,6-dimethoxybiphenylalanine analogues as VLA-4 antagonists.
Doherty GA; Kamenecka T; McCauley E; Van Riper G; Mumford RA; Tong S; Hagmann WK
Bioorg Med Chem Lett; 2002 Mar; 12(5):729-31. PubMed ID: 11858990
[TBL] [Abstract][Full Text] [Related]
7. Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists.
Tilley JW; Kaplan G; Rowan K; Schwinge V; Wolitzky B
Bioorg Med Chem Lett; 2001 Jan; 11(1):1-4. PubMed ID: 11140722
[TBL] [Abstract][Full Text] [Related]
8. The design and synthesis of potent cyclic peptide VCAM-VLA-4 antagonists incorporating an achiral Asp-Pro mimetic.
Fotouhi N; Joshi P; Fry D; Cook C; Tilley JW; Kaplan G; Hanglow A; Rowan K; Schwinge V; Wolitzky B
Bioorg Med Chem Lett; 2000 Jun; 10(11):1171-3. PubMed ID: 10866374
[TBL] [Abstract][Full Text] [Related]
9. The discovery of VLA-4 antagonists.
Tilley JW; Chen L; Sidduri A; Fotouhi N
Curr Top Med Chem; 2004; 4(14):1509-23. PubMed ID: 15544541
[TBL] [Abstract][Full Text] [Related]
10. N-Aroyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
Sidduri A; Tilley JW; Lou JP; Chen L; Kaplan G; Mennona F; Campbell R; Guthrie R; Huang TN; Rowan K; Schwinge V; Renzetti LM
Bioorg Med Chem Lett; 2002 Sep; 12(17):2479-82. PubMed ID: 12161162
[TBL] [Abstract][Full Text] [Related]
11. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
12. N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists.
Gutteridge CE; de Laszlo SE; Kamenecka TM; McCauley E; van Riper G; Mumford RA; Kidambi U; Egger LA; Tong S; Hagmann WK
Bioorg Med Chem Lett; 2003 Mar; 13(5):885-90. PubMed ID: 12617914
[TBL] [Abstract][Full Text] [Related]
13. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
14. Discovery and evaluation of potent, cysteine-based alpha4beta1 integrin antagonists.
Archibald SC; Head JC; Linsley JM; Porter JR; Robinson MK; Shock A; Warrellow GJ
Bioorg Med Chem Lett; 2000 May; 10(9):993-5. PubMed ID: 10853676
[TBL] [Abstract][Full Text] [Related]
15. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.
Jackson DY; Quan C; Artis DR; Rawson T; Blackburn B; Struble M; Fitzgerald G; Chan K; Mullins S; Burnier JP; Fairbrother WJ; Clark K; Berisini M; Chui H; Renz M; Jones S; Fong S
J Med Chem; 1997 Oct; 40(21):3359-68. PubMed ID: 9341911
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of potent and selective inhibitors of integrin VLA-4.
Wattanasin S; Weidmann B; Roche D; Myers S; Xing A; Guo Q; Sabio M; von Matt P; Hugo R; Maida S; Lake P; Weetall M
Bioorg Med Chem Lett; 2001 Nov; 11(22):2955-8. PubMed ID: 11677134
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of a biologically active cyclic LDV peptide analogue containing a type II' beta-turn mimetic.
Doyle PM; Harris JC; Moody CM; Sadler PJ; Sims M; Thornton JM; Uppenbrink J; Viles JH
Int J Pept Protein Res; 1996 Jun; 47(6):427-36. PubMed ID: 8836770
[TBL] [Abstract][Full Text] [Related]
18. Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists.
Chen L; Trilles R; Miklowski D; Huang TN; Fry D; Campbell R; Rowan K; Schwinge V; Tilley JW
Bioorg Med Chem Lett; 2002 Jun; 12(12):1679-82. PubMed ID: 12039589
[TBL] [Abstract][Full Text] [Related]
19. Squaric acid derivatives as VLA-4 integrin antagonists.
Porter JR; Archibald SC; Childs K; Critchley D; Head JC; Linsley JM; Parton TA; Robinson MK; Shock A; Taylor RJ; Warrellow GJ; Alexander RP; Langham B
Bioorg Med Chem Lett; 2002 Apr; 12(7):1051-4. PubMed ID: 11909715
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion antagonists: synthesis and evaluation of a novel series of phenylalanine based inhibitors.
Harriman GC; Schwender CF; Gallant D; Cochran NA; Briskin MJ
Bioorg Med Chem Lett; 2000 Jul; 10(14):1497-9. PubMed ID: 10915035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
